Mineralys Therapeutics(MLYS)
RADNOR, PABiotechnology
Focus: Mineralys Therapeutics is a public biotech company focused on small-molecule therapeutics for cardiovascular and nephrology indications, headquartered in Radnor, PA. The company is actively recruiting across commercial, clinical, and support functions with 339 open positions.
Profile data last refreshed 1h ago · AI intelligence enriched 4d ago
Funding Stage
PUBLIC
Open Jobs
325+262 this month
Hot — 319 jobs added in 30d
Net +262 (319 new, 57 removed). Aggressive expansion phase.
Should You Work at Mineralys Therapeutics?
AI assessmentMineralys offers growth-stage opportunity in focused therapeutic areas, but viability depends entirely on Phase 3 lorundrostat success and ability to extend cash runway.
Why Work Here
- Actively hiring 339 roles across the organization, indicating expansion phase with career advancement opportunities.
- Significant R&D investment: $169M spend in FY2025 (doubled from $70M in FY2024) signals commitment to pipeline development.
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Lorundrostat
Obstructive Sleep ApneaClinical Trials (1)
NCT06785454A Study to Assess the Efficacy and Safety of Lorundrostat in Participants With Obstructive Sleep Apnea and Hypertension
Phase 2Help build intelligence for Mineralys Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.